BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9544429)

  • 1. Evaluation of cell-mediated immunity and circulating immune complexes as prognostic indicators in cancer patients.
    Aziz M; Akhtar S; Malik A
    Cancer Detect Prev; 1998; 22(2):87-99. PubMed ID: 9544429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of circulating immune complexes in prognostic evaluation and management of genitourinary cancer patients.
    Aziz M; Das TK; Rattan A
    Indian J Cancer; 1997 Sep; 34(3):111-20. PubMed ID: 9491672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of circulating immune complexes in malignant tumours of head and neck.
    Das TK; Aziz M; Rattan A; Sherwani R
    J Indian Med Assoc; 1995 Jan; 93(1):3-7. PubMed ID: 7759908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of circulating immune complexes in cancer patients.
    Dass TK; Aziz M; Rattan A
    Jpn J Cancer Res; 1991 Nov; 82(11):1284-91. PubMed ID: 1752784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility and monitoring of breast cancer by circulating immune complexes.
    Dass TK; Aziz M; Rattan A; Tyagi SP
    Indian J Pathol Microbiol; 1992 Oct; 35(4):298-307. PubMed ID: 1344219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of circulating immune-complexes as prognostic indicators of lympho-reticular and mesenchymal malignancies in children.
    Aziz M; Dass TK; Rattan A
    J Trop Pediatr; 1992 Aug; 38(4):185-8. PubMed ID: 1527815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological status of patients in carcinoma head and neck.
    Vasenwala SM; Aziz M; Rattan A; Ahmad KN
    Indian J Cancer; 1989 Sep; 26(3):137-44. PubMed ID: 2630426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer humoral immune response: involvement of Lewis y through the detection of circulating immune complexes and association with Mucin 1 (MUC1).
    Isla Larrain M; Demichelis S; Crespo M; Lacunza E; Barbera A; Cretón A; Terrier F; Segal-Eiras A; Croce MV
    J Exp Clin Cancer Res; 2009 Aug; 28(1):121. PubMed ID: 19715603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Squamous cell carcinoma antigen, circulating immune complexes, and immunoglobulins in monitoring squamous cell carcinoma of head and neck: a study of the hellenic co-operative oncology group (HeCOG).
    Makrantonakis P; Pectasides D; Aggouridakis C; Visvikis A; Daniilidis J; Fountzilas G
    Am J Clin Oncol; 1999 Dec; 22(6):542-9. PubMed ID: 10597736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral immune response to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumours.
    von Mensdorff-Pouilly S; Gourevitch MM; Kenemans P; Verstraeten AA; Litvinov SV; van Kamp GJ; Meijer S; Vermorken J; Hilgers J
    Eur J Cancer; 1996 Jul; 32A(8):1325-31. PubMed ID: 8869094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum circulating immune complexes as prognostic indicators in premalignant and malignant lesions of oral cavity during and following radiotherapy.
    Rai S; Mody RN
    J Cancer Res Ther; 2012 Jan; 8 Suppl 1():S116-22. PubMed ID: 22322729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Circulating immune complexes in breast cancer].
    Abecassis J; Petit JC; Eber M; Klein T; Rodier D; Janser JC; Methlin G
    Bull Cancer; 1985; 72(1):42-7. PubMed ID: 3872691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of circulating immune complexes and serum immunoglobulins in oral cancer patients--a follow up study.
    Parveen S; Taneja N; Bathi RJ; Deka AC
    Indian J Dent Res; 2010; 21(1):10-5. PubMed ID: 20427899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating immune complexes and chemotherapy response in patients with head and neck cancer.
    Blazar BA; Fried MP; Strome M; Clark JR; Sereno P; Rodliff S; Caminear D
    Head Neck; 1989; 11(5):431-6. PubMed ID: 2807883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune complexes, serum proteins, cell-mediated immunity, and immune regulation in patients with squamous cell carcinoma of the head and neck.
    Veltri RW; Rodman SM; Maxim PE; Baseler MW; Sprinkle PM
    Cancer; 1986 Jun; 57(12):2295-308. PubMed ID: 3084060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of circulating immune complexes in pulmonary tuberculosis.
    Samuel AM; Ashtekar MD; Ganatra RD
    Clin Exp Immunol; 1984 Nov; 58(2):317-24. PubMed ID: 6437714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating immune complexes in breast and lung cancer, before and after chemotherapy.
    García MS; Barañao RI; Fernández O; Bordenave H; Rumi LS
    Allergol Immunopathol (Madr); 1987; 15(1):15-8. PubMed ID: 3604838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating immune complexes (CIC) as tumor marker in the follow-up of breast cancer.
    Neri B; Comparini T; Ciatto S; Cataliotti L; Distante V; Bartalucci S
    Cancer Detect Prev; 1985; 8(1-2):53-6. PubMed ID: 4064052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Circulating immune complexes and immunologic reactivity in breast cancer].
    Bilynskiĭ BT; Loginskiĭ VE; Fetsich TG
    Eksp Onkol; 1984; 6(3):50-2. PubMed ID: 6333978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of circulating immune complexes in patients with metastatic breast cancer.
    Krieger G; Kehl A; Wander HE; Salo AM; Rauschecker HF; Nagel GA
    Int J Cancer; 1983 Feb; 31(2):207-11. PubMed ID: 6826249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.